ESC 365 - Cardiac effects of chemotherapy - get ready for the session

EACVI 2025 Premium Access

Cardiac effects of chemotherapy - get ready for the session

Session: Cardiac effects of chemotherapy

Topic: Myocardial Disease

Speaker: Professor A. Barac (Fairfax, US)

Event: EACVI 2025

Congress Presentation

Add to my library

About the speaker

Professor Ana Barac

Inova Health System, Fairfax (United States of America)

10 presentations

1 follower

4 more presentations in this session

A case of immune checkpoint inhibitor myocarditis: challenging discrepancy between markedly elevated cardiac troponin concentrations and noninvasive imaging findings

Speaker: Mr R. Driessen (Amsterdam, NL)

A lighthouse in the storm: cardiac MRI reveals myocarditis in a patient treated for acute promyelocytic leukaemia with all-trans retinoic acid and idarubicin

Speaker: Doctor M. Zymatoura (Athens, GR)

Recurrent pericarditis in a patient treated for chronic myeloid leukemia: a clinical case

Speaker: Doctor A. Unger (Brussels, BE)

A case of severe cardiotoxicity following treatment with adriamycin and humanized anti-CD20 monoclonal antibody for non-Hodgkin lymphoma

Speaker: Doctor V. Popadic (Belgrade, RS)

Access the full session

Cardiac effects of chemotherapy

Speakers: Professor A. Barac, Mr R. Driessen, Doctor M. Zymatoura, Doctor A. Unger, Doctor V. Popadic

About the event

EACVI 2025

11 December - 13 December 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources